Hemlibra 150 mg/mL solution for injection, Hemlibra 30 mg/mL solution for injection
BO41423
Phase 3 small_molecule active
Quick answer
Hemlibra 150 mg/mL solution for injection, Hemlibra 30 mg/mL solution for injection for Mild or moderate hemophilia A without FVIII inhibitors is a Phase 3 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Mild or moderate hemophilia A without FVIII inhibitors
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active